Establishment of iPSC-Derived MSCs Expressing hsa-miR-4662a-5p for Enhanced Immune Modulation in Graft-Versus-Host Disease (GVHD)
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26020847 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Susie Lee und 7 weiteren Autor:innen. Beteiligte Einrichtung: Catholic High-Performance Cell Therapy Center & Department of Medical Life Science, College of Medicine, The Catholic University of Korea, Seocho-gu,…. Hauptthemen laut MEDLINE: MicroRNAs, Graft vs Host Disease, Mesenchymal Stem Cells, Induced Pluripotent Stem Cells. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Food and Drug Safety, Korean Ministry of Food and Drug Safety (MFDS), RegenInnopharm Inc..
Abstract (Originalsprache)
The immune-modulatory effects of mesenchymal stromal cells (MSCs) are widely used to treat inflammatory disorders, with indoleamine 2,4-dioxygenase-1 (IDO-1) playing a pivotal role in suppressing stimulated T-cell proliferation. Taking that three-dimensional (3D) cultures enhance MSCs’ anti-inflammatory properties compared with two-dimensional (2D) cultures, the differentially expressed miRNAs were examined. Thus, we identified hsa-miR-4662a-5p (miR-4662a) as a key inducer of IDO-1 via its suppression of bridging integrator-1 (BIN-1), a negative regulator of the IDO-1 gene. The IDO-1-inducing potential of miR-4662a was conserved across primary MSCs from various donors and sources but exhibited variability. Notably, iPSC-derived MSCs (iMSCs) demonstrated superior IDO-1 induction and immune-modulatory efficacy compared with their donor-matched primary MSCs. Accordingly, iMSCs expressing miR-4662a (4662a/iMSC) exhibited stronger suppressive effects on T-cell proliferation and more potent suppressive effects on graft-versus-host disease (GVHD), improving survival rates and reducing tissue damage in the liver and gut. Our results point to the therapeutic potential of standardized, off-the-shelf 4662a/iMSC as a robust immune-modulating cell therapy for GVHD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Catholic High-Performance Cell Therapy Center & Department of Medical Life Science, College of Medicine, The Catholic University of Korea, Seocho-gu, Seoul 06591, Republic of Korea.
- Department of Medical Sciences, College of Medicine, The Catholic University of Korea, Seocho-gu, Seoul 06591, Republic of Korea.
- RegenInnopharm Inc., Seocho-gu, Seoul 06591, Republic of Korea.
- Department of Pathology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seocho-gu, Seoul 06591, Republic of Korea.
ORCID-Profile: Chan Kwon Jung
Förderung
- Ministry of Food and Drug Safety
- Korean Ministry of Food and Drug Safety (MFDS)
- RegenInnopharm Inc.
Zitieren
APA
Lee, S., Kim, E. W., Lee, H. R., Lim, S. U., Jung, C. K., Kang, Y. J., Jung, G. A., & Oh, I. H. (2025). Establishment of iPSC-Derived MSCs Expressing hsa-miR-4662a-5p for Enhanced Immune Modulation in Graft-Versus-Host Disease (GVHD). International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26020847
Vancouver
Lee S, Kim EW, Lee HR, Lim SU, Jung CK, Kang YJ, et al. Establishment of iPSC-Derived MSCs Expressing hsa-miR-4662a-5p for Enhanced Immune Modulation in Graft-Versus-Host Disease (GVHD). International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26020847
BibTeX
@article{Lee2025,
author = {Lee, Susie and Kim, Eung-Won and Lee, Hae-Ri and Lim, Sun-Ung and Jung, Chan Kwon and Kang, Young-Ju and Jung, Gyung-Ah and Oh, Il-Hoan},
title = {Establishment of iPSC-Derived MSCs Expressing hsa-miR-4662a-5p for Enhanced Immune Modulation in Graft-Versus-Host Disease (GVHD)},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26020847}
}
EUVIMED